Cerebral hypoperfusion correlates with mild and parenchymal loss with severe multi-infarct dementia

J Kawamura1, J S Meyer, Y Terayama

  • 1Cerebral Blood Flow Laboratory, Veterans Affairs Medical Center, Houston, TX 77211.

Insights

Chronic cerebral hypoperfusion contributes to early multi-infarct dementia (MID), while significant brain tissue loss drives advanced stages. Understanding these factors is key for managing cognitive impairments in MID patients.

Area of Science:

  • Neurology
  • Neuroimaging
  • Geriatrics

Background:

  • Multi-infarct dementia (MID) is a common cause of cognitive impairment in older adults.
  • The relative contributions of cerebral hypoperfusion and brain tissue loss to MID progression are not fully understood.

Purpose of the Study:

  • To investigate the roles of cerebral hypoperfusion and brain parenchyma loss in mild versus severe multi-infarct dementia.
  • To correlate cognitive function with neuroimaging measures in MID patients.

Main Methods:

  • Stable xenon contrasted computed tomography (CT) was used to measure local cerebral blood flow (LCBF).
  • Brain parenchyma volume loss was estimated using CT-derived ratios of infarcted brain and cerebrospinal fluid to total intracranial volume.
  • 26 MID patients (mild and severe) and 14 age-matched controls were studied.

Main Results:

  • Severe MID patients showed significantly higher brain parenchyma volume loss compared to controls.
  • Mild MID patients did not differ from controls in brain loss but exhibited decreased cortical gray matter LCBF.
  • Cognitive test scores correlated with both hypoperfusion and brain tissue loss measures.

Conclusions:

  • Chronic cerebral hypoperfusion is a significant factor in early-stage MID cognitive decline.
  • Brain tissue loss due to cerebral infarction is a key determinant of advanced MID.
  • These findings highlight distinct pathogenetic mechanisms in different stages of MID.

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...